The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mccourt Thomas A since 2013.
This trader's CIK number is 1478448.
At the time of last reporting, Mccourt Thomas A was the Chief Executive Officer of Ironwood Pharmaceuticals Inc. (stock ticker symbol IRWD).
Also see all insider trading activities at Ironwood Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | IRWD | 0 | $0 | 139,064 | $244,752 | 0 | $0 |
| 2024 | IRWD | 0 | $0 | 244,782 | $3,136,115 | 0 | $0 |
| 2023 | IRWD | 0 | $0 | 410,820 | $4,754,635 | 221,924 | $2,585,414 |
| 2022 | IRWD | 0 | $0 | 127,920 | $1,433,842 | 0 | $0 |
| 2021 | IRWD | 0 | $0 | 115,372 | $1,293,009 | 0 | $0 |
| 2020 | IRWD | 0 | $0 | 25,874 | $320,341 | 119,988 | $1,189,281 |
| 2019 | IRWD | 0 | $0 | 228,896 | $2,144,774 | 220,000 | $1,073,600 |
| 2018 | IRWD | 0 | $0 | 33,343 | $649,008 | 30,000 | $164,400 |
| 2017 | IRWD | 0 | $0 | 30,000 | $546,000 | 30,000 | $164,400 |
| 2013 | IRWD | 0 | $0 | 40,000 | $680,000 | 40,000 | $219,200 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | XLRN | 0 | $0 | 23,272 | $2,110,002 | 23,272 | $734,813 |
1. Ironwood Pharmaceuticals Inc (IRWD)
2. Acceleron Pharma Inc (XLRN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-10 | IRWD | Sale | 139,064 | 1.76 | 244,752 |
| 2024-05-20 | IRWD | Sale | 67,618 | 6.45 | 436,136 |
| 2024-02-12 | IRWD | Sale | 177,164 | 15.24 | 2,699,979 |
| 2023-05-30 | IRWD | Sale | 26,632 | 10.70 | 284,962 |
| 2023-05-08 | IRWD | Sale | 21,148 | 10.62 | 224,591 |
| 2023-03-27 | IRWD | Sale | 46,129 | 10.67 | 492,196 |
| 2023-03-03 | IRWD | Sale | 33,756 | 11.22 | 378,742 |
| 2023-02-27 | IRWD | Sale | 30,004 | 11.41 | 342,345 |
| 2023-02-28 | IRWD | Sale | 31,227 | 11.31 | 353,177 |
| 2023-01-05 | IRWD | Sale | 110,962 | 12.07 | 1,339,311 |
| 2023-01-05 | IRWD | Option Ex | 110,962 | 11.65 | 1,292,707 |
| 2023-01-05 | IRWD | Sale | 110,962 | 12.07 | 1,339,311 |
| 2023-01-05 | IRWD | Option Ex | 110,962 | 11.65 | 1,292,707 |
| 2022-08-01 | IRWD | Sale | 23,229 | 11.35 | 263,649 |
| 2022-06-30 | IRWD | Sale | 19,959 | 11.58 | 231,125 |
| 2022-05-23 | IRWD | Sale | 36,308 | 11.50 | 417,542 |
| 2022-02-28 | IRWD | Sale | 48,424 | 10.77 | 521,526 |
| 2021-12-22 | IRWD | Sale | 46,327 | 11.41 | 528,591 |
| 2021-11-23 | IRWD | Sale | 52,644 | 11.58 | 609,617 |
| 2021-05-24 | IRWD | Sale | 1,716 | 12.25 | 21,021 |
| 2021-02-26 | IRWD | Sale | 14,685 | 9.11 | 133,780 |
| 2020-12-14 | IRWD | Option Ex | 99,988 | 9.89 | 988,881 |
| 2020-05-11 | IRWD | Sale | 1,697 | 10.35 | 17,563 |
| 2020-02-21 | IRWD | Sale | 4,177 | 11.63 | 48,578 |
| 2020-01-24 | IRWD | Option Ex | 20,000 | 10.02 | 200,400 |
| 2020-01-24 | IRWD | Sale | 20,000 | 12.71 | 254,200 |
| 2019-08-30 | IRWD | Option Ex | 220,000 | 4.88 | 1,073,600 |
| 2019-08-30 | IRWD | Sale | 220,000 | 9.24 | 2,032,800 |
| 2019-05-10 | IRWD | Sale | 4,055 | 10.53 | 42,699 |
| 2019-02-20 | IRWD | Sale | 4,800 | 14.31 | 68,688 |
| 2019-02-21 | IRWD | Sale | 41 | 14.32 | 587 |
| 2018-07-06 | IRWD | Option Ex | 30,000 | 5.48 | 164,400 |
| 2018-07-06 | IRWD | Sale | 30,000 | 20.00 | 600,000 |
| 2018-02-21 | IRWD | Sale | 3,343 | 14.66 | 49,008 |
| 2017-05-15 | IRWD | Option Ex | 30,000 | 5.48 | 164,400 |
| 2017-05-15 | IRWD | Sale | 30,000 | 18.20 | 546,000 |
| 2013-03-11 | IRWD | Option Ex | 40,000 | 5.48 | 219,200 |
| 2013-03-11 | IRWD | Sale | 40,000 | 17.00 | 680,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-09-11 | XLRN | Option Ex | 23,272 | 31.57 | 734,813 |
| 2020-09-11 | XLRN | Sale | 23,272 | 90.67 | 2,110,002 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mccourt Thomas A (Chief Executive Officer of Ironwood Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.